Taipei, Tuesday, May 21, 2013 16:05 (GMT+8)
showers in the vicinity
Taipei
27°C
PCB maker Apex to see capacity utilization rate drop to 80% in 4Q12 - related company info
Ingrid Lee, Taipei; Steve Shen, DIGITIMES [Thursday 11 October 2012]
  • Apex Biotechnology
  • Brief

    Full name: Apex Biotechnology

    Chinese name: 五鼎生物技術股份有限公司

    Short name: Apex

    Stock code: 1733

    Tax ID: 16130182

    Market: TSE

    Established: 2 Dec 1997

    Paid in capital: NT$985.31 million

    Listed on TSE: 17 Sep 2001

    Website: www.apexbio.com

  • Financial performance
    Apex [1733] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    21-May 578   81.40 82.70 81.20 82.20+0.80+0.98%  
    20-May 373 260 30,429,817 81.60 82.00 81.20 81.40-0.20-0.25% 81.60 81.40
    17-May 469 345 38,380,869 80.80 82.10 80.80 81.60+0.80+0.99% 81.70 81.60
    16-May 379 314 30,724,997 80.60 81.30 80.60 80.80+0.30+0.37% 81.00 80.80
    15-May 830 552 66,996,302 82.00 82.00 80.40 80.50-1.50-1.83% 80.90 80.50
    14-May 581 428 47,702,031 82.60 82.60 81.80 82.00-0.80-0.97% 82.10 82.00
    13-May 847 542 69,813,488 81.10 83.10 81.00 82.80+1.70+2.10% 82.80 82.60
    • Source: TSE, compiled by Digitimes

    Apex: Consolidated revenues, Apr 2012 - Apr 2013 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Apr-13

    182

    (2%)

    (9.5%)

    706

    (4.4%)

    Mar-13

    186

    17.4%

    (8.8%)

    524

    (2.4%)

    Feb-13

    158

    (11.9%)

    (12.5%)

    338

    1.5%

    Jan-13

    180

     

    18%

    180

    18%

    Apr-12

    201

    (1.2%)

     

    738

     

    Mar-12

    204

    12.7%

     

    537

     

    Feb-12

    181

    18.8%

     

    333

     

    Jan-12

    152

     

     

    152

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, May 2013

    Apex: Non-consolidated revenues, Dec 2011 - Dec 2012 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Dec-12

    158

    (0.3%)

    2.8%

    2,026

    8%

    Nov-12

    158

    (4.3%)

    (4.5%)

    1,868

    8.4%

    Oct-12

    166

    16.3%

    (7%)

    1,710

    9.8%

    Sep-12

    142

    (7.4%)

    (26.1%)

    1,544

    12%

    Aug-12

    154

    (3.9%)

    (10.7%)

    1,402

    18.2%

    Jul-12

    160

    (3.2%)

    (6.5%)

    1,248

    23.1%

    Jun-12

    165

    (10.4%)

    (0.2%)

    1,088

    29.1%

    May-12

    184

    (8.5%)

    12.9%

    923

    36.2%

    Apr-12

    201

    (1.2%)

    34.2%

    738

    43.7%

    Mar-12

    204

    12.7%

    47.8%

    537

    47.5%

    Feb-12

    181

    18.8%

    41.7%

    333

    47.4%

    Jan-12

    152

    (0.8%)

    54.7%

    152

    54.7%

    Dec-11

    154

    (7.4%)

    30.8%

    1,876

    7.2%

    *Figures are not consolidated
    Source: TSE, compiled by Digitimes, May 2013

    Apex: Consolidated revenues, 4Q11 - 4Q12 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    4Q-12

    482

    5.7%

    (3.1%)

    2,026

    8%

    3Q-12

    456

    (17.2%)

    (14.9%)

    1,544

    12%

    2Q-12

    551

    2.6%

    15%

    1,088

    29.1%

    1Q-12

    537

    7.9%

    47.5%

    537

    47.5%

    4Q-11

    498

    (7.1%)

    13.6%

    1,876

    7.2%

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, May 2013

    Apex: Non-consolidated revenues, 4Q11 - 4Q12 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    4Q-12

    482

    5.7%

    (3.1%)

    2,026

    8%

    3Q-12

    456

    (17.2%)

    (14.9%)

    1,544

    12%

    2Q-12

    551

    2.6%

    15%

    1,088

    29.1%

    1Q-12

    537

    7.9%

    47.5%

    537

    47.5%

    4Q-11

    498

    (7.1%)

    13.6%

    1,876

    7.2%

    *Figures are not consolidated
    Source: TSE, compiled by Digitimes, May 2013

    Apex: Consolidated balance sheet, 4Q11 - 4Q12 (NT$k)

    Item

    4Q-2012

    3Q-2012

    2Q-2012

    1Q-2012

    4Q-2011

    Current assets

    1,818,585

    2,016,677

    1,412,117

    1,695,678

    1,532,186

    Intangible assets

    17,776

    18,038

    19,440

    20,570

    21,088

    Other assets

    7,636

    7,524

    7,492

    7,483

    7,481

    Assets

    2,748,000

    2,619,772

    2,015,119

    2,299,518

    2,139,073

    Current liabilities

    332,528

    331,662

    431,355

    382,048

    368,297

    Other liabilities

    18,542

    19,098

    19,548

    20,007

    20,465

    Liabilities

    735,180

    733,374

    450,903

    402,055

    388,762

    Stockholders' equity

    2,012,820

    1,886,398

    1,564,216

    1,897,463

    1,750,311

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, May 2013

    Apex: Non-consolidated balance sheet, 4Q11 - 4Q12 (NT$k)

    Item

    4Q-2012

    3Q-2012

    2Q-2012

    1Q-2012

    4Q-2011

    Current assets

    1,809,827

    2,007,371

    1,407,388

    1,690,956

    1,532,186

    Long-term investments

    7,621

    7,769

    4,729

    4,722

    5,189

    Intangible assets

    17,776

    18,038

    19,440

    20,570

    21,088

    Other assets

    7,588

    7,524

    7,492

    7,483

    7,481

    Assets

    2,746,815

    2,618,235

    2,015,119

    2,299,518

    2,144,262

    Current liabilities

    332,479

    331,325

    431,355

    382,048

    373,486

    Other liabilities

    18,542

    19,098

    19,548

    20,007

    20,465

    Liabilities

    735,131

    733,037

    450,903

    402,055

    393,951

    Stockholders' equity

    2,011,684

    1,885,198

    1,564,216

    1,897,463

    1,750,311

    *Figures are not consolidated
    Source: TSE, compiled by Digitimes, May 2013

    Apex: Consolidated income statement, 4Q11 - 4Q12 (NT$k)

    Item

    4Q-2012

    3Q-2012

    2Q-2012

    1Q-2012

    4Q-2011

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Gross sales

    486,607

     

    460,802

     

    555,932

     

    542,752

     

    502,393

     

    Operating revenue

    481,967

    99%

    456,170

    99%

    550,926

    99.1%

    537,023

    98.9%

    497,557

    99%

    Gross profit (loss) from operations

    190,327

    39.1%

    185,765

    40.3%

    197,343

    35.5%

    234,927

    43.3%

    226,710

    45.1%

    Operating expenses

    52,896

    10.9%

    50,176

    10.9%

    52,530

    9.4%

    50,165

    9.2%

    53,144

    10.6%

    Operating income (loss)

    137,431

    28.2%

    135,589

    29.4%

    144,813

    26%

    184,762

    34%

    173,566

    34.5%

    Non-operating revenues and gains

    1,866

    0.4%

    1,307

    0.3%

    21,854

    3.9%

    2,090

    0.4%

    -4,629

    -0.9%

    Income from continuing operations before income tax

    131,412

    27%

    125,346

    27.2%

    170,792

    30.7%

    168,113

    31%

    169,116

    33.7%

    Net income (loss)

    125,637

    25.8%

    106,215

    23.1%

    144,865

    26.1%

    145,729

    26.9%

    145,236

    28.9%

    Fully-diluted earnings per share (NT$)

    1.2

     

    1

     

    1.5

     

    1.5

     

    1.5

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, May 2013

    Apex: Non-consolidated income statement, 4Q11 - 4Q12 (NT$k)

    Item

    4Q-2012

    3Q-2012

    2Q-2012

    1Q-2012

    4Q-2011

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Gross sales

    486,607

     

    460,802

     

    555,932

     

    542,752

     

    502,393

     

    Operating revenue

    481,967

    99%

    456,170

    99%

    550,926

    99.1%

    537,023

    98.9%

    497,557

    99%

    Gross profit (loss) from operations

    190,327

    39.1%

    185,765

    40.3%

    197,343

    35.5%

    234,927

    43.3%

    226,710

    45.1%

    Operating expenses

    52,708

    10.8%

    49,514

    10.7%

    52,530

    9.4%

    50,165

    9.2%

    53,144

    10.6%

    Operating income (loss)

    137,619

    28.3%

    136,251

    29.6%

    144,813

    26%

    184,762

    34%

    173,566

    34.5%

    Non-operating revenues and gains

    1,858

    0.4%

    1,307

    0.3%

    21,852

    3.9%

    2,090

    0.4%

    -4,629

    -0.9%

    Income from continuing operations before income tax

    131,476

    27%

    125,546

    27.2%

    170,792

    30.7%

    168,113

    31%

    169,116

    33.7%

    Net income (loss)

    125,701

    25.8%

    106,415

    23.1%

    144,865

    26.1%

    145,729

    26.9%

    145,236

    28.9%

    Fully-diluted earnings per share (NT$)

    1.2

     

    1

     

    1.5

     

    1.5

     

    1.5

     

    *Figures are not consolidated
    Source: TSE, compiled by Digitimes, May 2013

  • Apex Biotechnology full profile
Realtime news
  • BenQ Materials expects performance to improve in 2Q13

    Displays | 5min ago

  • AMD falls to 4th rank MPU supplier in 2012, says IC Insights

    Bits + chips | 11min ago

  • Innolux expected to ship 1 million TOD units in 2013

    Displays | 23min ago

  • TV panel pricing expected to further drop in May, says WitsView

    Displays | 39min ago

  • China market: Third-party e-payment services generate CNY1.2 trillion in 1Q13 total trade value, says Analysys

    IT + CE | 43min ago

  • China market: Online advertising valued at CNY18 billion in 1Q13, says Analysys

    IT + CE | 56min ago

  • Demand for large-size driver ICs to boom in 2H13, say backend firms

    Bits + chips | 1h 18min ago

  • Touch screen IC, LED driver IC suppliers to post strong performance in May

    Bits + chips | 1h 21min ago

  • TPK expected to see decline in touch screen notebook market share during 2Q13

    Displays | 1h 25min ago

Pause
 | 
View more

21-May-2013 markets closed

 LastChange

TAIEX (TSE)8383.05+6.00+0.07% 

TSE electronic316.85+0.06+0.02% 

GTSM (OTC)120.38+0.64+0.53% 

OTC electronic144.61+0.55+0.38% 

COMPUTEX TAIPEI Summit Forum 2013
Trends and forecast for 2013 touch panel market
2013 global tablet forecast
  • Samsung reportedly to outsource more chips

    Samsung Electronics reportedly is looking to expand the purchase of memory products, including mobile DRAM chips and eMMC NAND devices, from outside.

  • Micron reaches deal to acquire Elpida

    Micron Technology and Elpida Memory's trustees have reached an agreement for Micron to acquire Elpida. Micron also announced a separate agreement with...

  • Taiwan DRAM firms mull fab sales

    Taiwan-based DRAM chipmakers including Powerchip Technology and ProMOS Technologies are considering selling fabs in order to preserve cash and strengthen...

  • Samsung foundry biz expanding

    Specializing in the manufacture of memory chips and LCD panels, Samsung's component operations are undergoing a focus shift to advanced process design...

  • 2H 2012 global TFT panel market forecast

    Digitimes Research predicts there will be a total of 389 million large-sized TFT LCD panels shipped in 2H12, with 195 million in the third quarter and 194 million in the fourth quarter - with the total representing a 7.6% increase over the first half of this year.

  • Trends in the China video market

    In addition to strong potential video content demand in China, the market has developed rapidly due to government intervention and delays in establishing copyright protections.

  • 4Q12 trends in the Greater China touch panel industry

    In the second half of 2012, the market focus is on the iPhone 5, which uses in-cell touch screen technology. Due to the integration of display panels and touch panel functions, the high technological threshold will mean Taiwan touch panel makers are unable to enter the iPhone supply chain.